Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement
Until more evidence becomes available, this pragmatic, multidisciplinary consensus statement aims to support shared decision-making and improve safety for patients taking glucagon-like peptide-1 receptor agonists, dual glucose-dependent insulinotropic peptide receptor agonists and sodium-glucose cotransporter-2 inhibitors during the peri-operative period.
Authors
- Dileep N. Lobo (ORCID: https://orcid.org/0000-0003-1187-5796)
- Omar G. Mustafa (ORCID: https://orcid.org/0000-0003-3123-809X)
- Ken Clare (ORCID: https://orcid.org/0000-0001-7054-444X)
- Kariem El‐Boghdadly (ORCID: https://orcid.org/0000-0002-9912-717X)
- Philippa Fabb
- Anil Patel (ORCID: https://orcid.org/0000-0003-1634-7650)
- Nicholas Levy (ORCID: https://orcid.org/0000-0002-2225-1535)
- Jugdeep Dhesi (ORCID: https://orcid.org/0000-0003-0815-0233)
- Dimitri J. Pournaras (ORCID: https://orcid.org/0000-0001-8798-920X)
- Ketan Dhatariya (ORCID: https://orcid.org/0000-0003-3619-9579)
- Philip Newland‐Jones (ORCID: https://orcid.org/0000-0001-6056-0008)
- Andrew McKechnie
Institutions
- University of East Anglia (GB)
- North Bristol NHS Trust (GB)
- University of Nottingham (GB)
- King's College London (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- West Suffolk NHS Foundation Trust (GB)
- Norfolk and Norwich University Hospitals NHS Foundation Trust (GB)
- Portsmouth Hospitals NHS Trust (GB)
- Queen's Medical Centre (GB)
- King's College Hospital (GB)
- Lewisham and Greenwich NHS Trust (GB)
- University of Southampton (GB)
- University College London (GB)
- University of Pennsylvania (US)
Publication Details
- Journal
- Anaesthesia
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1111/anae.16541
- Citations
- 74
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 100.21
Funders
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Edwards Lifesciences
- Cardinal Health
- Royal College of Surgeons of England
- Novo Nordisk